We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLH icon
276
Clean Harbors
CLH
$17.2B
$9.98M 0.07%
87,414
+25,258
+41% +$2.95M
DNLI icon
277
Denali Therapeutics
DNLI
$3.79B
$9.95M 0.07%
357,878
– –
IOVA icon
278
Iovance Biotherapeutics
IOVA
$2.04B
$9.93M 0.07%
1,553,920
-115,000
-7% -$898K
AXS icon
279
AXIS Capital
AXS
$7.81B
$9.83M 0.07%
181,395
-40,878
-18% -$2.21M
BSY icon
280
Bentley Systems
BSY
$11.2B
$9.73M 0.07%
263,280
+37,061
+16% +$1.34M
TNET icon
281
TriNet
TNET
$3.23B
$9.37M 0.06%
138,262
+24,856
+22% +$1.71M
NRIX icon
282
Nurix Therapeutics
NRIX
$2.45B
$9.34M 0.06%
850,575
+25,000
+3% +$302K
UMPQ
283
DELISTED
Umpqua Holdings Corp
UMPQ
$9.32M 0.06%
522,191
-53,380
-9% -$1.01M
AYI icon
284
Acuity Brands
AYI
$9.99B
$9.29M 0.06%
56,102
-6,009
-10% -$1.07M
HRB icon
285
H&R Block
HRB
$5.98B
$9.26M 0.06%
253,623
+24,139
+11% +$981K
MORF
286
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$9.23M 0.06%
344,933
– –
SYF icon
287
Synchrony
SYF
$24.4B
$9.19M 0.06%
279,615
-386,302
-58% -$13.2M
OPLN
288
Openlane
OPLN
$4.28B
$9.11M 0.06%
698,288
+59,626
+9% +$799K
FSLR icon
289
First Solar
FSLR
$21.4B
$9.1M 0.06%
60,774
-6,492
-10% -$962K
KEY icon
290
KeyCorp
KEY
$23.8B
$9.02M 0.06%
517,941
-162,632
-24% -$2.86M
ARRY icon
291
Array Technologies
ARRY
$740M
$9.01M 0.06%
466,009
+9,410
+2% +$179K
VRAY
292
DELISTED
ViewRay, Inc.
VRAY
$8.99M 0.06%
2,006,504
-96,677
-5% -$421K
UPWK icon
293
Upwork
UPWK
$1.18B
$8.96M 0.06%
857,841
+324,190
+61% +$4M
REG icon
294
Regency Centers
REG
$14.9B
$8.95M 0.06%
143,188
-72,630
-34% -$4.46M
MAN icon
295
ManpowerGroup
MAN
$2.6B
$8.91M 0.06%
107,069
-18,899
-15% -$1.52M
ATVI
296
DELISTED
Activision Blizzard
ATVI
$8.9M 0.06%
116,324
-22,642
-16% -$1.68M
DLTR icon
297
Dollar Tree
DLTR
$24.8B
$8.87M 0.06%
62,739
-69,667
-53% -$10.4M
BE icon
298
Bloom Energy
BE
$46.6B
$8.85M 0.06%
462,738
+77,436
+20% +$1.52M
ALLY icon
299
Ally Financial
ALLY
$13.1B
$8.83M 0.06%
361,036
-149,849
-29% -$3.99M
BLDP
300
Ballard Power Systems
BLDP
$754M
$8.81M 0.06%
1,841,439
+432,856
+31% +$2.46M
10 11
12
13 14

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.